Highly cited researchers
Monash researchers recognised for international influence in the 2018 Highly Cited Researchers list (HiCi)
Monash University researchers have been recognised for their success in the 2018 list of Highly Cited (HiCi) researchers released by Clarivate Analytics, with 22 Monash academics featuring. The HiCi list recognises the world’s leading researchers in 22 fields across sciences and the social sciences, who place in the top one per cent of the most highly cited researchers in their field consistently over a 10-year period.
|Associate Professor Julie Arblaster||Cross-Field||Science|
|Associate Professor Qiaoliang Bao||Cross-Field||Engineering|
|Professor Rinaldo Bellomo AO||Clinical Medicine||Medicine, Nursing and Health Sciences|
|Professor Rachelle Buchbinder||Cross-Field||Medicine, Nursing and Health Sciences|
|Professor William Charman||Pharmacology and Toxicology||Pharmacy and Pharmaceutical Sciences|
|Professor Arthur Christopoulos||Pharmacology & Toxicology||Pharmacy and Pharmaceutical Sciences|
|Professor Steven Chown||Cross-Field||Science|
|Professor Mark Cooper||Cross-Field||Medicine, Nursing and Health Sciences|
|Professor Thomas Davis||Cross-Field||Pharmacy and Pharmaceutical Sciences|
|Professor Alex Fornito||Psychiatry/Psychology||Medicine, Nursing and Health Sciences|
|Professor Michael Fuhrer||Physics||Science|
|Professor Henry Krum*||Clinical Medicine||Medicine, Nursing and Health Sciences|
|Professor Charles Mackay||Immunology||Medicine, Nursing and Health Sciences|
|Professor Christopher Porter||Pharmacology & Toxicology||Pharmacy and Pharmaceutical Sciences|
|Professor Colin Pouton||Pharmacology & Toxicology||Pharmacy and Pharmaceutical Sciences|
|Professor Jamie Rossjohn||Immunology||Medicine, Nursing and Health Sciences|
|Professor Patrick Sexton||Pharmacology & Toxicology||Pharmacy and Pharmaceutical Sciences|
|Professor Melissa Southey||Cross-Field||Medicine, Nursing and Health Sciences|
|Professor Leone Spiccia*||Cross-Field||Science|
|Professor Gary Williamson||Agricultural Sciences||Medicine, Nursing and Health Sciences|
|Professor Murat Yucel||Psychiatry/Psychology||Medicine, Nursing and Health Sciences|
|Professor Paul Zimmet AO||Cross-Field||Medicine, Nursing and Health Sciences|
Associate Professor Julie moved to the School of Earth, Atmosphere and Environment in February 2016 after more than a decade at the Australian Bureau of Meteorology. She spent a number of years at the National Center for Atmospheric Research in the United States and still maintains strong collaborative ties with colleagues there. Her research interests include climate extremes, decadal variability and the role of the Antarctic ozone hole in shifting storm tracks.
Associate Professor Qiaoliang Bao is an Associate Professor and ARC Future Fellow at Monash University. His research interests include photonic and optoelectronic devices based on low-dimensional materials including graphene, h-BN, black phosphorus, layered transition metal dichalcogenides, topological insulators and perovskites. He has published more than 130 papers with more than 10,000 total citations.
Professor Rinaldo Bellomo AO MBBS MD FRACP FCICM FAHMS is an Honorary Professor in the Faculty of Medicine at Monash University. Each year for the past five years (2014-2018), Professor Bellomo has been named one of the world's most influential scientific minds of our time. Clarivate Analytics publishes "The world's most influential scientific minds" based on its analysis of data over the previous 11 years using Web of Science and InCites platforms to determine which researchers have produced work that is most frequently acknowledged by peers. Prof Bellomo is one of the researchers identified as "influencing the future direction of their field, and of the world", "on the cutting edge of their field" and "publishing work that their peers recognise as vital to the advancement of their science".
Rachelle Buchbinder is an Australian NHMRC Senior Principal Research Fellow. She has been the Director of the Monash Department of Clinical Epidemiology since its inception in 2001 and a Professor in the Monash University Department of Epidemiology and Preventive Medicine since 2007. She is a rheumatologist and clinical epidemiologist who combines clinical practice with research in a wide range of multidisciplinary projects relating to arthritis and musculoskeletal conditions.
Bill Charman is Dean, Faculty of Pharmacy and Pharmaceutical Sciences at Monash University; and the Chair of the FIP (International Pharmaceutical Federation) Education initiative (FIPEd). His research has been characterised by a multidisciplinary and collaborative approach to address major issues in drug discovery (especially for neglected diseases such as malaria), drug delivery and the pharmaceutical sciences.
Arthur Christopoulos is the theme Leader, Drug Discovery Biology, at the Monash Institute of Pharmaceutical Sciences (MIPS). Arthur is currently a NHMRC Senior Principal Research Fellow at MIPS, and an elite pharmacologist who has pioneered much of the key research into allostery and biased agonism in drug discovery targeting G Protein Coupled-Receptor (GPCR) biology.
Steven works in the School of Biological Sciences at Monash University as a Professor.
His research interests cover a range of fields, including, most prominently: 1. Macrophysiology - the evolution of large-scale physiological variation and its ecological implications, especially in the context of adaptation to and mitigation of the impacts of environmental change. 2. Invasion biology - understanding the impacts of non-indigenous organisms on all aspects of biodiversity. 3. The biology and conservation of Antarctic systems with particular emphasis on science and conservation policy in the region.
Mark Cooper AO is Head of the recently formed (1 January 2017) Diabetes Department in the Central Clinical School at Monash University. He was formerly Chief Scientific Officer, Baker IDI Heart and Diabetes Institute, and maintains an active clinical practice at The Alfred as a senior endocrinologist. His research and clinical interests are in diabetes and its complications, including kidney disease, heart disease and blindness.
Professor Cooper has published nearly 600 papers (see PubMed search Cooper ME).